Multivalent capture of circulating tumor cells using tetrahedral DNA framework-targeted nanomagnetic beads integrated microfluidic device
Colloids and Surfaces B: Biointerfaces · 2026
DOI: 10.1016/j.colsurfb.2025.115142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026. Verfasst von Chuang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 18 Yangsu Road, Suzhou 215000, PR China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Lab-On-A-Chip Devices, DNA, Cell Separation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
Circulating tumor cells (CTCs), though rare and highly heterogeneous, are closely associated with tumor initiation, progression, and prognosis. Their low abundance, structural fragility, phenotypic diversity, and size variability make efficient enrichment particularly challenging. To address these limitations, we developed a novel CTC isolation platform that combines tetrahedral DNA nanostructure-based trivalent aptamer magnetic nanospheres (TDF-Cocktail-MNP) with a magnetic microfluidic separation device. This system enhances the capture of viable, phenotypically diverse CTCs and supports reliable downstream analysis. The TDF structure presents three aptamers: EpCAM targets epithelial CTCs, Vimentin captures mesenchymal types, and EGFR binds to cells overexpressing EGFR-a key marker in triple-negative breast cancer. This multi-target approach enables efficient isolation of heterogeneous CTC populations from whole blood samples. Captured CTCs are enriched using the IsoFlux System, which reduces mechanical stress and preserves cell viability by avoiding repeated magnetic manipulation. After nuclease-mediated removal of the DNA scaffold, cells are classified and quantified through immunocytochemistry. Validated with both spiked and clinical breast cancer samples, this platform shows strong potential for liquid biopsy applications, offering robust CTC detection and valuable insights for personalized cancer diagnostics and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 18 Yangsu Road, Suzhou 215000, PR China.
- Medical Laboratory of the Third Affiliated Hospital of Shenzhen University, 33 Zhongyuan Road, Buji St, Shenzhen 518000, PR China.
- Department of Thyroid and Breast Surgery, Third Affiliated Hospital of Shenzhen University, Shenzhen 518000, PR China.
- Department of Critical Care Medicine, Third Affiliated Hospital of Shenzhen University, Shenzhen 518000, PR China.
- Medical Laboratory of the Third Affiliated Hospital of Shenzhen University, 33 Zhongyuan Road, Buji St, Shenzhen 518000, PR China. Electronic address: douxiaowen573@163.com.
Förderung
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Zhang, C., Zhang, X., Zhang, J., Peng, M., & Dou, X. (2026). Multivalent capture of circulating tumor cells using tetrahedral DNA framework-targeted nanomagnetic beads integrated microfluidic device. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2025.115142
Vancouver
Zhang C, Zhang X, Zhang J, Peng M, Dou X. Multivalent capture of circulating tumor cells using tetrahedral DNA framework-targeted nanomagnetic beads integrated microfluidic device. Colloids and Surfaces B: Biointerfaces. 2026. doi:10.1016/j.colsurfb.2025.115142
BibTeX
@article{Zhang2026,
author = {Zhang, Chuang and Zhang, Xinhua and Zhang, Jian and Peng, Mian and Dou, Xiaowen},
title = {Multivalent capture of circulating tumor cells using tetrahedral DNA framework-targeted nanomagnetic beads integrated microfluidic device},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2026},
doi = {10.1016/j.colsurfb.2025.115142}
}
EUVIMED